XBiotech Inc

XBiotech Inc. is a Canadian clinical-stage biotechnology company that develops novel antibody therapies derived from naturally occurring human antibodies. It operates in the United States, aiming to create targeted treatments for various medical conditions, including cancer, inflammatory, and infectious diseases. Operating within the Healthcare sector, XBiotech Inc. employs its proprietary True Human™ technology. This innovative approach seeks to provide safer and more effective solutions for patients by harnessing natural human immunity to fight disease. Monitor the XBIT share price by adding it to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.